Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryan J Sullivan

Showing results (231-240 of 328) with videos related to

Pageof 33
Sort By:
Nature Communications|June 26, 2026
Personalized targeting of BCL2 family proteins overcomes acquired resistance to BRAF-MEK inhibitors in preclinical melanomaVashisht Gopal Y N, Evelyn de Groot, Kaley Loftin, et al.
JAMA Oncology|December 4, 2015
Ipilimumab Therapy in Patients With Advanced Melanoma and Preexisting Autoimmune DisordersDouglas B Johnson, Ryan J Sullivan, Patrick A Ott, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 18, 2018
Molecular signatures of circulating melanoma cells for monitoring early response to immune checkpoint therapyXin Hong, Ryan J Sullivan, Mark Kalinich, et al.
European Journal of Cancer (Oxford, England : 1990)|January 24, 2018
Rechallenge with BRAF-directed treatment in metastatic melanoma: A multi-institutional retrospective studySara Valpione, Matteo S Carlino, Johanna Mangana, et al.
European Journal of Cancer (Oxford, England : 1990)|March 18, 2018
Corrigendum to "Rechallenge with BRAF-directed treatment in metastatic melanoma: A multi-institutional retrospective study*" [Eur J Cancer 91 (2018) 116-124]Sara Valpione, Matteo S Carlino, Johanna Mangana, et al.
Nature Communications|September 1, 2025
Mature and migratory dendritic cells promote immune infiltration and response to anti-PD-1 checkpoint blockade in metastatic melanomaJiekun Yang, Cassia Wang, Doris Fu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 4, 2019
A Fatty Acid Oxidation-dependent Metabolic Shift Regulates the Adaptation of <i>BRAF</i>-mutated Melanoma to MAPK InhibitorsAndrea Aloia, Daniela Müllhaupt, Christophe D Chabbert, et al.
Journal of Translational Medicine|July 20, 2023
Perspectives in Immunotherapy: meeting report from Immunotherapy Bridge (Naples, November 30th-December 1st, 2022)Paolo A Ascierto, Antonio Avallone, Carlo Bifulco, et al.
Journal of Translational Medicine|September 7, 2020
Perspectives in melanoma: meeting report from the "Melanoma Bridge" (December 5th-7th, 2019, Naples, Italy)Paolo A Ascierto, Igor Puzanov, Sanjiv S Agarwala, et al.
Nature Cancer|February 5, 2022
Palbociclib demonstrates intracranial activity in progressive brain metastases harboring cyclin-dependent kinase pathway alterationsPriscilla K Brastianos, Albert E Kim, Nancy Wang, et al.
Pageof 33

Showing results (231-240 of 328) with videos related to

Sort By:
Pageof 33
Nature Communications|June 26, 2026
Personalized targeting of BCL2 family proteins overcomes acquired resistance to BRAF-MEK inhibitors in preclinical melanomaVashisht Gopal Y N, Evelyn de Groot, Kaley Loftin, et al.
JAMA Oncology|December 4, 2015
Ipilimumab Therapy in Patients With Advanced Melanoma and Preexisting Autoimmune DisordersDouglas B Johnson, Ryan J Sullivan, Patrick A Ott, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 18, 2018
Molecular signatures of circulating melanoma cells for monitoring early response to immune checkpoint therapyXin Hong, Ryan J Sullivan, Mark Kalinich, et al.
European Journal of Cancer (Oxford, England : 1990)|January 24, 2018
Rechallenge with BRAF-directed treatment in metastatic melanoma: A multi-institutional retrospective studySara Valpione, Matteo S Carlino, Johanna Mangana, et al.
European Journal of Cancer (Oxford, England : 1990)|March 18, 2018
Corrigendum to "Rechallenge with BRAF-directed treatment in metastatic melanoma: A multi-institutional retrospective study*" [Eur J Cancer 91 (2018) 116-124]Sara Valpione, Matteo S Carlino, Johanna Mangana, et al.
Nature Communications|September 1, 2025
Mature and migratory dendritic cells promote immune infiltration and response to anti-PD-1 checkpoint blockade in metastatic melanomaJiekun Yang, Cassia Wang, Doris Fu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 4, 2019
A Fatty Acid Oxidation-dependent Metabolic Shift Regulates the Adaptation of <i>BRAF</i>-mutated Melanoma to MAPK InhibitorsAndrea Aloia, Daniela Müllhaupt, Christophe D Chabbert, et al.
Journal of Translational Medicine|July 20, 2023
Perspectives in Immunotherapy: meeting report from Immunotherapy Bridge (Naples, November 30th-December 1st, 2022)Paolo A Ascierto, Antonio Avallone, Carlo Bifulco, et al.
Journal of Translational Medicine|September 7, 2020
Perspectives in melanoma: meeting report from the "Melanoma Bridge" (December 5th-7th, 2019, Naples, Italy)Paolo A Ascierto, Igor Puzanov, Sanjiv S Agarwala, et al.
Nature Cancer|February 5, 2022
Palbociclib demonstrates intracranial activity in progressive brain metastases harboring cyclin-dependent kinase pathway alterationsPriscilla K Brastianos, Albert E Kim, Nancy Wang, et al.
Pageof 33